BlackRock Investment Management’s Axogen AXGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$811K Buy
90,071
+562
+0.6% +$4.84K ﹤0.01% 2814
2016
Q3
$808K Sell
89,509
-158
-0.2% -$1.28K ﹤0.01% 2801
2016
Q2
$617K Buy
89,667
+86,125
+2,432% +$487K ﹤0.01% 2939
2016
Q1
$19K Sell
3,542
-381
-10% -$1.93K ﹤0.01% 3388
2015
Q4
$20K Buy
3,923
+269
+7% +$1.33K ﹤0.01% 3428
2015
Q3
$15K Hold
3,654
﹤0.01% 3526
2015
Q2
$11K Buy
3,654
+376
+11% +$1.21K ﹤0.01% 3671
2015
Q1
$11K Buy
3,278
+912
+39% +$3.13K ﹤0.01% 3610
2014
Q4
$8K Hold
2,366
﹤0.01% 3748
2014
Q3
$6K Hold
2,366
﹤0.01% 3840
2014
Q2
$7K Buy
+2,366
New +$6.44K ﹤0.01% 3756

Other funds holding AXGN

BlackRock Investment Management's AXGN Position: Q4 2016 in Review

BlackRock Investment Management increased its Axogen (AXGN) stake by 0.63% in Q4 2016, buying an estimated $4.84K and bringing the position to 90,071 shares worth $811K. The position accounts for ﹤0.01% of the portfolio, ranked #2814.

BlackRock Investment Management first reported a position in AXGN in Q2 2014 and has held it in 11 quarters since. 88 funds tracked by Wall St. Rank hold AXGN as of Q4 2016.

  • BlackRock Investment Management held 90,071 shares of Axogen worth $811K as of Q4 2016.
  • BlackRock Investment Management bought 562 Axogen shares in Q4 2016, an estimated $4.84K.
  • Axogen made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #2814 holding.
  • BlackRock Investment Management first reported a position in Axogen in Q2 2014 and has held it in 11 quarters since.
  • 88 funds tracked by Wall St. Rank held Axogen as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.